GeneSYS ID Inc fka GNID

[StockMedic1]

TO ALL $RXSFD - read the filings and news for yourselves. DO NOT rely on anyone else's interpretation of the disclosures made in those filings, good or bad. Pay attention to the press releases and compare them with what the CEO has said she is going to do. She has been delivering on every single thing she has said she would do since the end of the summer. She also has an OPEN DOOR policy, so if you read something critical of the company, whether blatant or by inference, call Lorraine Yarde, speak to her directly, and you will learn the truths. Her number is at the company website at http://www.rxdrugsafe.com She returns every call and is eager to answer questions.

The company is emerging from a R/S apparently UNSCATHED. They company had its designation "D" removed. The company has uplisted to the QB. The company just started its sales program, and its with CVS and the CEO already announced initial sales through that program. The CEO announced to have a plan in place by the end of the year to resolve any remaining convertible debt. The technology is current and applicable, the healthcare market is huge, and the CEO has done everything she said she would do.

If you hear something that doesn't make any sense to you, call the CEO. She will tell you exactly what is going on.